New strength of Purdue Pharma's pain patch Butrans gets FDA OK

09/25/2013 | Drug Store News

The FDA approved the 15-microgram-per-hour strength of Purdue Pharma's chronic pain patch Butrans, or buprenorphine. The drug, already approved in 20-microgram, 10-microgram and 5-microgram strengths, is indicated for moderate to severe chronic pain requiring a continuous opioid analgesic for an extended period.

View Full Article in:

Drug Store News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Attorney
Blue Cross Blue Shield of Louisiana
Baton Rouge, LA
Senior or Principal Consultant
PAREXEL International
Nationwide, SL_Nationwide
Chief Financial Officer
Health Alliance Plan of Michigan
Southfield, MI
Senior Vice-President Managed Care Mid-Atlantic Region
Mercy Health System
Conshohocken, PA
Associate Chief Financial Officer
Commonwealth Care Alliance
Boston, MA